000	00000nam 2200000zi 4500
001	9.937240
003	CaOODSP
005	20240611110605
006	m     o  d f
007	cr |n|||||||||
008	240419e20041214onc     ob   f|0| 0 eng d
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aH14-609/2004E-PDF
245	00|aSummary report of the inspections of clinical trials conducted in 2003/2004 / |cHealth Products and Food Branch Inspectorate.
264	1|a[Ottawa] : |bHealth Canada, Health Products and Food Branch Inspectorate, |cDecember 14, 2004.
300	|a1 online resource (20 pages)
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aIssued also in French under title: Rapport sommaire des inspections d'essais cliniques réalisées en 2003 et 2004.
500	|aCover title.
504	|aIncludes bibliographical references.
520	|a"This document provides the results and analysis of the findings of inspections of clinical trials conducted by the Health Products and Food Branch Inspectorate (Inspectorate) in 2003/2004. This is the second annual report of inspections of clinical trials, and is intended to assess compliance of the conduct of clinical trials under the purview of Division 5 of the Food and Drug Regulations “Drugs for clinical trials involving human subjects” "--Executive Summary, page 3.
650	0|aClinical trials|zCanada.
710	1 |aCanada.|bHealth Canada. |bHealth Products and Food Branch Inspectorate, |eissuing body.
775	08|tRapport sommaire des inspections d'essais cliniques réalisées en 2003 et 2004 / |w(CaOODSP)9.937241
856	40|qPDF|s143 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-609-2004-eng.pdf
856	41|qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-clinical-practices/reports/summary-report-inspections-clinical-trials-conducted-2003-2004.html